NRXP SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 15, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 23, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 14, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 18, 2025

NT 10-Q

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Aug 14, 2025

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Jun 3, 2026

424B5

PENDING FIXED PRICE OFFERING | Bank: BTIG

Jun 2, 2026

424B5

February 2026 ATM | Offering amount: $20,000,000 | Bank: H.C. Wainwright & Co.

Feb 17, 2026

424B3

UPDATED | SHARE RESALE REGISTRATION | Offering amount: $150,000,000

Dec 22, 2025

424B5

REGISTERED OFFERING

Aug 18, 2025

424B3

UPDATED | ATM | Offering amount: $20,000,000 | Amount sold to date: $1,827,434

Apr 17, 2025

Registrations

TYPE

HEADLINE

FILED AT

S-3/A

SHARE RESALE REGISTRATION | Offering amount: $150,000,000

Dec 12, 2025

Form RW - Registration Withdrawal Request

Jun 24, 2025

S-3

June 2025 SHELF EFFECTIVE, DATED 2025-12-22

Jun 20, 2025

Form D - Notice of Exempt Offering of Securities - Item 06b

Mar 7, 2025

S-1

SHARE RESALE REGISTRATION | Shares amount: 3,304,374 | Warrants amount: 227,494 | Warrants exercise price: $2.42

Nov 14, 2024

S-3/A

SHELF EFFECTIVE

Jun 14, 2022

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Nov 5, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Nov 5, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Feb 24, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Feb 23, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Feb 13, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Sep 5, 2024

Ownerships

TYPE

HEADLINE

FILED AT

ABRAMS MICHAEL S (Reporting)

Nov 4, 2026

Javitt Jonathan C (Reporting)

Nov 4, 2026

SCHEDULE 13G/A

Anson Funds Management LP (Filed by)

May 15, 2026

Casper Joseph Michael (Reporting)

Feb 17, 2026

Casper Joseph Michael (Reporting)

Feb 17, 2026

S-3/A

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Dec 12, 2025

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Dec 23, 2025

CORRESP

Form CORRESP - Correspondence

Dec 18, 2025

LETTER

Form UPLOAD - SEC-generated letter

Jun 24, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Jun 22, 2022

CORRESP

Form CORRESP - Correspondence

Jun 16, 2022

LETTER

Form UPLOAD - SEC-generated letter

Jun 13, 2022

NRx Pharmaceuticals, Inc. NRXP · SEC Filings